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A major part of the genome of higher eukaryotes consists of
non-coding sequences. In former times, these sequences were
called‘junk-DNA’asnospeciﬁcfunction couldbe attributedto
them. More recent research has shown that small non-coding
RNAs are contained in these parts of the genome. These non-
coding RNAs have a fundamental role in gene regulation.
Regulation of gene expression in eukaryotes is multifaceted
and additional layers of complexity are constantly discovered.
In a recent article published in Molecular Systems Biology,
Varda Rotter et al describe a network that combines several of
such regulatory layers by integrating the concerted actions of
thetranscription factorsp53, E2F1, their respectivetargetsand
three clusters of microRNAs (Brosh et al, 2008).
MicroRNAs (miRNAs) are a relatively recently identiﬁed
means for gene regulation. They are small, endogenous non-
coding RNAs, between 19 and 25nt in length. In some cases,
miRNAs are organised in clusters and transcribed as poly-
cistrons, which are cleaved in the nucleus into shorter
precursor miRNAs. These precursor miRNAs are exported
into the cytoplasm where they are further processed. Mature
miRNAsareloadedontotheRISCcomplex,whichguidesthem
to their mRNA target. Usually, miRNAs base-pair imperfectly
in the untranslated region of their target mRNA, and control
gene expression at the post-transcriptional level (reviewed in
Le Sage and Agami, 2006). Unlike siRNA, miRNAs are of
endogenous origin and alterations in their expression are
associated with a number of diseases, including cancer.
One example of how miRNAs contribute to the control of
malignant transformation is demonstrated in the work by Ran
Broshandco-workerswhoinvestigatedthreeclustersofmiRNA,
including the miRs-106b/93/25, miR-17-92 and miR-106a-92
polycistrons. These three clusters are coordinately regulated by
the activityof the transcription factor p53, one ofthe key tumour
suppressor proteins. Together with the retinoblastoma (pRb)
protein, p53 controls G1/S transition during the cell cycle.
Transition of cells into S phase requires the activity of the E2F1
transcription factor. Normally, this protein is sequestered and
kept inactive by the pRb protein. At the end of G1, pRb is
phosphorylated by cyclin-dependent kinases (CDKs), which
release E2F1 from its constraint (Sun et al, 2007; Calzone et al,
2008). The transcription factor p53 controls pRb phosphoryla-
tionbyinducingexpressionofp21,aCDKinhibitor.Infact,p21is
one of the many p53 targets, which collectively mediate the
antiproliferative and pro-apoptotic response induced by onco-
genic stress signals or by cellular senescence (Riley et al, 2008).
Ran Brosh and co-workers show that the three miRNA
clusters above (miR-17-92, miR-106b/93/25 and miR-106a-92)
are downregulated by p53 and that this set of miRNAs also
targets a group of antiproliferative factors, including pRb, p21
and p57. Their regulation by p53 turns out, however, to be
indirect. Thus, none of the three miRNA clusters harbours a
p53-binding site. Instead, they are controlled by the transcrip-
tion factor E2F1. Strikingly, genes that are silenced by these
E2F1-regulated miRNAs are themselves directly controlled by
E2F1. The transcription factor E2F1, the miRNA cluster and
their common target genes appear, therefore, to form a
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Figure 1 In unstressed proliferating cells, p53 is inactive, whereas E2F1
induces expression of antiproliferative genes. At the same time, E2F1 stimulates
transcription of a set of miRNAs that silence those antiproliferative factors
(A). During replicative senescence, p53 is activated and stimulates expression
of antiproliferative genes. Simultaneously, it inhibits E2F1 activity, thus
preventing transcription of miRNAs that target antiproliferative regulators (B).
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proliferating cells, p53 is inactive and pRb is phosphorylated.
E2F1 can therefore drive transcription of antiproliferative
genes, while at the same time it ensures that only low levels of
protein are made through the activation of transcription of
corresponding miRNAs (Figure 1A). Conversely, in senescent
cells,p53 is active, which leads to the interruption of this loop:
on activation, p53 reduces E2F1 activity by stimulating
transcription of the p21 gene, which prevents phosphorylation
of pRb thus keeping E2F-1 in check (Figure 1B). In addition,
p53 enhances the transcription of miRNAs from the miR-34
cluster, which controls E2F1 abundance (Kumamoto et al,
2008). As a consequence, transcription of the miRNA clusters
is no longeractivatedbyE2F1 and expressionof their targetsis
therefore upregulated.
With a detailed analysis of this regulatory network, Ran
Brosh and co-workers have not only characterised the inter-
playof several components for gene regulation, they have also
identiﬁed a new mechanism by which p53 inhibits prolifera-
tion and controls cell fate. Nevertheless, several questions
remain open. Although the E2F-centered feed-forward loop
motif may appear at ﬁrst sight as potentially wasteful, this
motif has been proposed to have potential consequences on
regulatory kinetics and sensitivity to noise (Shalgi et al, 2007).
What are the physiological implications of this speciﬁc
arrangement within the context of p53-regulated proliferation?
Furthermore, why does p53 interrupt only this feed-forward
loop during senescence and not when it is activated by other
conditions such as treatment with doxorubicin? Certainly,
future investigations will provide us with answers to these
questions. Moreover, with the current rapid advances in
genomics and proteomics and further developments in our
understanding of miRNA biology, we will hopefully gain
deeper insight into the physiological signiﬁcance of increas-
ingly larger networks that combine multiple layers of regula-
tion into integrated cellular decision mechanisms.
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